Abstract:Although stem cell-derived extracellular vesicles (EVs) have remarkable therapeutic potential for various diseases, the therapeutic efficacy of EVs is limited due to their degradation and rapid diffusion after administration, hindering their translational applications. Here, we developed a new generation of collagen-binding EVs, by chemically conjugating a collagen-binding peptide SILY to EVs (SILY-EVs), which were designed to bind to collagen in the extracellular matrix (ECM) and form an EV-ECM complex to improve EVs' in situ retention and therapeutic efficacy after transplantation. Methods: SILY was conjugated to the surface of mesenchymal stem/stromal cell (MSC)-derived EVs by using click chemistry to construct SILY-EVs. Nanoparticle tracking analysis (NTA), ExoView analysis, cryogenic electron microscopy (cryo-EM) and western-blot analysis were used to characterize the SILY-EVs. Fluorescence imaging (FLI), MTS assay, ELISA and reverse transcription-quantitative polymerase chain reaction (RT-qPCR) were used to evaluate the collagen binding and biological functions of SILY-EVs in vitro. In a mouse hind limb ischemia model, the in vivo imaging system (IVIS), laser doppler perfusion imaging (LDPI), micro-CT, FLI and RT-qPCR were used to determine the SILY-EV retention, inflammatory response, blood perfusion, gene expression, and tissue regeneration. Results:In vitro, the SILY conjugation significantly enhanced EV adhesion to the collagen surface and did not alter the EVs' biological functions. In the mouse hind limb ischemia model, SILY-EVs presented longer in situ retention, suppressed inflammatory responses, and significantly augmented muscle regeneration and vascularization, compared to the unmodified EVs. Conclusion: With the broad distribution of collagen in various tissues and organs, SILY-EVs hold promise to improve the therapeutic efficacy of EV-mediated treatment in a wide range of diseases and disorders. Moreover, SILY-EVs possess the potential to functionalize collagen-based biomaterials and deliver therapeutic agents for regenerative medicine applications.

Extracellular Vesicle Mobility in Collagen I Hydrogels Is Influenced by Matrix-Binding Integrins

Extracellular vesicle mobility in collagen I hydrogels is modulated by RGD-binding integrins

Convection and extracellular matrix binding control interstitial transport of extracellular vesicles

Extracellular vesicles are integral and functional components of the extracellular matrix

Nonspecific membrane-matrix interactions influence diffusivity of lipid vesicles in hydrogels

Extracellular vesicles: Critical players during cell migration

Extracellular vesicles and the extracellular matrix: a new paradigm or old news?

Proteomic and functional characterisation of extracellular vesicles from collagen VI deficient human fibroblasts reveals a role in cell motility

Extracellular Vesicles and the Immune System: From Immunological Function to Therapeutic Application

Extracellular Vesicles: from Bench to Bedside

Extracellular Vesicles: An Emerging Mechanism Governing the Secretion and Biological Roles of Tenascin-C

Extracellular Vesicles in Cell Biology and Medicine

Extracellular vesicles: mediators of intercellular communication in tissue injury and disease

Extracellular vesicles - on the cusp of a new language in the biological sciences

Engineered extracellular vesicles with high collagen-binding affinity present superior in situ retention and therapeutic efficacy in tissue repair

Biological functions of extracellular vesicles from mammalian cells

The mini player with diverse functions: extracellular vesicles in cell biology, disease, and therapeutics

Extracellular Vesicles and Intercellular Communication: Challenges for In Vivo Molecular Imaging and Tracking

The biology and function of extracellular vesicles in immune response and immunity

FIGURE 3 from Small Extracellular Vesicles Promote Stiffness-mediated Metastasis

Extracellular vesicles: A dive into their role in the tumor microenvironment and cancer progression